NASDAQ:IOVA

Iovance Biotherapeutics Stock Predictions

etoro logo Buy IOVA
*Your capital is at risk
$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

IOVA Prediction Chart

IOVA Predictions History

Latest community submissions for IOVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 28, 2026 $3.54 +3.30% $3.38 X 95.17% 0
Apr 28, 2026 $3.50 +2.06% $3.38 X 96.43% 0
Apr 28, 2026 Bullish $3.38 X 0
Apr 21, 2026 $3.69 -2.42% $3.70 V 99.69% 5
Apr 21, 2026 $3.66 -3.23% $3.70 V 98.86% 2
Apr 21, 2026 $3.70 -2.02% $3.70 V 99.90% 10
Apr 21, 2026 $4.00 +5.82% $3.70 X 91.89% 0
Apr 7, 2026 Bullish $3.32 V 1
Apr 1, 2026 $3.64 +3.73% $3.45 X 94.47% 0
Apr 1, 2026 $3.59 +2.33% $3.45 X 95.89% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for IOVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT IOVANCE BIOTHERAPEUTICS, INC.
Iovance Biotherapeutics
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE